Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
EV/EBIT

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 27.3647.7027.698.479.60

What is the latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS ?

The latest EV/EBIT ratio of GLENMARK PHARMACEUTICALS is 27.36 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202527.36
Mar202447.70
Mar202327.69
Mar20228.47
Mar20219.60

How is EV/EBIT of GLENMARK PHARMACEUTICALS Trending?

Years EV/EBIT % Change
Mar2025 27.36
-42.64
Mar2024 47.7
72.26
Mar2023 27.69
226.92
Mar2022 8.47
-11.77
Mar2021 9.6 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare EV/EBIT ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹54,951.4 Cr 5.8% 5.6% 27.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹439,378.0 Cr 2.8% 6.7% 2.8% Stock Analytics
DIVIS LABORATORIES ₹171,996.0 Cr 1.9% -0.5% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹125,959.0 Cr 0.1% 3.4% 15.8% Stock Analytics
CIPLA ₹123,666.0 Cr 1.8% -3.2% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹105,008.0 Cr 2.7% 0.4% 3.4% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

5.8%

5.6%

27.7%

SENSEX

0.6%

1.3%

7%


You may also like the below Video Courses